Department of Endocrinology, Xuzhou Third People's Hospital, Xuzhou, Jiangsu, China.
Department of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou, Jiangsu, China.
Diabet Med. 2021 Feb;38(2):e14491. doi: 10.1111/dme.14491. Epub 2020 Dec 20.
To assess whether group cognitive behavioural therapy (GCBT) delivered by general practitioners reduces anxiety and depression and improves glycaemic levels in adults with type 2 diabetes mellitus.
We conducted a community-based cluster randomized controlled trial in adults with type 2 diabetes mellitus from 48 communities in China. Participants received either GCBT plus usual care (UC) or UC only. General practitioners were trained in GCBT before intervention in the intervention group. The primary outcome was glycated haemoglobin (HbA ) concentration. Outcome data were collected from all participants at baseline, 2 months, 6 months and 1 year. The secondary outcomes were depression (Patient Health Questionnaire-9; PHQ-9) and anxiety (General Anxiety Disorder questionnaire; GAD-7).
The GCBT group showed greater improvement in GAD-7 and PHQ-9 scores, respectively, than the UC group after 2 months post-baseline (T = -6.46, p < 0.0001; T = -5.29, p < 0.001), 6 months (T = -4.58, p < 0.001; T = -4.37, p < 0.001) and 1 year post-intervention (T = -3.91, p < 0.001; T = -3.57, p < 0.001). There was no difference in HbA values between the GCBT and UC groups at 2 months while the values were lower in the GCBT group at 6 months and 1 year (T = -6.83, p < 0.001; T = -4.93, p < 0.001, respectively). Subgroup analysis indicated a long-term effect of GCBT only for mild and moderate anxiety and mild depression groups. Similarly, HbA values reduced only in the mild and moderate anxiety and the mild depression groups.
General practitioners can deliver GCBT interventions. GCBT plus UC is superior to UC for reducing mild/moderate anxiety and depression, and improving glycaemic levels.
Chinese clinical trials registration (ChiCTR-IOP-16008045).
评估由全科医生提供的团体认知行为疗法(GCBT)是否可以降低 2 型糖尿病成人的焦虑和抑郁水平并改善血糖水平。
我们在中国 48 个社区开展了一项基于社区的群组随机对照试验,纳入了 2 型糖尿病成人患者。参与者接受 GCBT 联合常规护理(UC)或仅接受 UC。在干预组中,全科医生在干预前接受了 GCBT 培训。主要结局指标为糖化血红蛋白(HbA )浓度。所有参与者在基线、2 个月、6 个月和 1 年时均收集结局数据。次要结局指标为抑郁(患者健康问卷-9;PHQ-9)和焦虑(广泛性焦虑障碍问卷;GAD-7)。
与 UC 组相比,GCBT 组在基线后 2 个月(T=-6.46,p<0.0001;T=-5.29,p<0.001)、6 个月(T=-4.58,p<0.001;T=-4.37,p<0.001)和 1 年时(T=-3.91,p<0.001;T=-3.57,p<0.001)的 GAD-7 和 PHQ-9 评分分别有更大的改善。在 2 个月时,GCBT 和 UC 组之间的 HbA 值没有差异,而在 6 个月和 1 年时 GCBT 组的 HbA 值较低(T=-6.83,p<0.001;T=-4.93,p<0.001)。亚组分析表明,GCBT 仅对轻度和中度焦虑以及轻度抑郁组具有长期效果。同样,仅在轻度和中度焦虑以及轻度抑郁组中,HbA 值才降低。
全科医生可以提供 GCBT 干预。GCBT 联合 UC 优于 UC,可降低轻度/中度焦虑和抑郁水平并改善血糖水平。
中国临床试验注册(ChiCTR-IOP-16008045)。